Cash & equivalents increased 41.8%
Cash & equivalents changed +41.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +41.8% from the comparable as-filed period.
Gross margin changed +1310 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed +63.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed +37.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed +190.7% from the comparable as-filed period.
Operating margin changed +1250 basis points from the comparable as-filed period.
Research & development changed +21.6% from the comparable as-filed period.
Revenue changed +29.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +109.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Debt changed -0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.